Study Reveals Public Perceptions and Challenges of Innovation in 10 Countries

Jan.24.2025
Study Reveals Public Perceptions and Challenges of Innovation in 10 Countries
PMI's independent survey shows most believe innovation can address key issues, but hurdles like misinformation and outdated policies exist.

On January 22nd, Philip Morris International (PMI) announced on its official website that an independent investigation commissioned by the company and conducted by Povaddo in 10 countries across Africa, the Americas, Asia, and Europe, revealed in a white paper titled "Innovation Under Pressure: Harnessing Complexity to Drive Change" that the majority of people believe innovation has the potential to address key issues in the next 10 to 20 years.


The survey results indicate that innovation faces many challenges in driving social change, including misleading information, outdated biases, and policymakers struggling to keep pace with rapid technological advancements. About 80% of respondents believe that misleading information weakens the application of crucial innovations, while 90% of respondents agree that it is crucial for the government to ensure that the public has access to accurate innovation information and to establish clear and fair regulatory measures.


A survey showed that approximately three-quarters (71%) of respondents believe that disruptive innovation can promote the development and deployment of vaccines, while nearly two-thirds (62%) believe that innovation can ensure everyone has access to high-quality and affordable healthcare services. However, there is a significant divergence of opinion on whether innovation can reduce smoking rates (49%) and illegal drug use (43%), reflecting the complexity and stubbornness of these issues.


While the public is optimistic about the opportunities brought by technology and innovation in the coming years (76% agree), the majority of people (74%) also agree that discussions around new innovations have become polarized, leading to consumer confusion. Furthermore, in these 10 countries, eight in ten citizens believe that misleading information is hindering progress.


The CEO of PMI, Jacek Olczak, stated that the company is committed to creating healthier alternatives to cigarettes through scientific and technological innovation, with a focus on global public health. However, the progress of innovation is often hindered by misunderstandings. Olczak emphasized that before dismissing the possibility of innovation, especially policymakers, should take the time to review scientific and public health evidence and make decisions based on facts rather than outdated assumptions.


The evidence supporting smoke-free alternatives to cigarettes is increasing, as seen in countries like Sweden with the lowest smoking rates in Europe, or Japan where smoking rates have decreased by 45% since introducing heated tobacco products in 2014. In other industries, accepting such innovation and allowing it to replace more harmful products is considered common sense. A small minority of opponents should not hinder the progress of around 1 billion adult smokers worldwide and public health.


Roughly two-thirds of survey participants (64%) are concerned that the pace of technological change is too fast for society and the economy to adapt. Respondents also pointed out a lack of information about the pros and cons of these innovations, public skepticism and distrust (often driven by social media), and thorny ethical issues. The public is looking to the government to take action and accelerate the adoption of advancements that can have a positive impact. The vast majority (90%) of respondents believe that it is very important for the government to ensure that the public has access to accurate information and establish clear and fair regulations. In addition, 87% emphasized the government's responsibility to address the challenge of misleading information, 83% highlighted the importance of public-private sector collaboration, and 82% believed it is necessary to promote open and balanced public debate on emerging innovations.


PMI calls on governments, public health institutions, and civil society to embrace proactive change and engage in constructive dialogue based on science and evidence.


The methodology of this survey is based on an international survey conducted by Povaddo from December 13th to 27th, 2024. The survey included 10,250 ordinary citizens aged 21 and above in 10 countries: Argentina, Brazil, France, Italy, Mexico, South Africa, South Korea, Spain, the United Kingdom, and the United States. The overall margin of error for the survey results is ±1%.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

JUUL Purchasers Ask Ninth Circuit to Preserve Antitrust Classes in Case Over Altria’s $12.8 Billion Investment
JUUL Purchasers Ask Ninth Circuit to Preserve Antitrust Classes in Case Over Altria’s $12.8 Billion Investment
Private antitrust litigation stemming from Altria's 2018 $12.8 billion investment for a 35% economic interest in JUUL is advancing before the U.S. Court of Appeals for the Ninth Circuit. Direct purchasers, indirect purchasers and indirect resellers of JUUL products filed answering briefs this week seeking to preserve class certifications granted by a California federal court in February. Altria and JUUL argue that individual consumers and large distributors differ too much in purchasing terms to remain in a single direct-purchaser class, while a separate dispute concerns whether California antitrust law can apply to indirect purchasers across 27 jurisdictions. A September trial has been put on hold during the appeal.
Sep.23
From Nicotine Pouches to Soft Candy Forms: China Tobacco Hubei explores adjustable-release oral nicotine products
From Nicotine Pouches to Soft Candy Forms: China Tobacco Hubei explores adjustable-release oral nicotine products
China-based China Tobacco Hubei Industrial Co., Ltd. has filed a patent application covering an oral nicotine product and its preparation method. The patent proposes a soft candy-shaped oral nicotine product containing nicotine ingredients, gelling agents, sweeteners and alkaline pH regulators. Through formulation adjustments and homogeneous or dual-layer structures, the technology aims to achieve different nicotine release profiles. The filing reflects exploration of new oral nicotine product formats and controlled nicotine delivery approaches.
Aug.06
U.S. Military Could Test Nicotine Pouches and Vapes for Smoking Cessation as Washington Examiner Cites ZYN and Potential $4 Billion Reduction in Related Defense Costs
U.S. Military Could Test Nicotine Pouches and Vapes for Smoking Cessation as Washington Examiner Cites ZYN and Potential $4 Billion Reduction in Related Defense Costs
The House-passed FY2027 National Defense Authorization Act includes a provision authorizing the defense secretary to conduct a one-year smoking-cessation pilot for active-duty service members. Section 707 lists counseling, nicotine gum and patches alongside what the bill calls "electric nicotine delivery systems," nicotine pouches and heat-not-burn products. A recent Washington Examiner op-ed cited ZYN as an example in arguing for the provision, but the legislation does not name any commercial brand or supplier. ZYN is made by PMI-owned Swedish Match USA, with specified products holding FDA marketing authorizations and modified risk orders.
Sep.20
South Korea Imports 12,126 Kg of Nicotine Analogues From April to August After Bringing Synthetic Nicotine Under Tobacco Law
South Korea Imports 12,126 Kg of Nicotine Analogues From April to August After Bringing Synthetic Nicotine Under Tobacco Law
South Korea's liquid-vape market is showing changes across raw-material imports, product types and sales channels after synthetic nicotine came under the Tobacco Business Act on April 24. Customs data show nicotine-analogue imports totaled 12,126 kilograms from April through August, while synthetic-nicotine imports over the same five months totaled 231,663 kilograms, just 39.3% of the amount imported in March alone. Physical liquid-vape stores tracked in Seoul and Gyeonggi Province fell 9.9%, unmanned outlets edged higher and online sales listings increased from 27,774 to 42,437. Government testing of 105 liquid inhalation products promoted as nicotine-free separately found nicotine in 13 and 6-methylnicotine in 12.
Sep.22
NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
At the 2026 New Approaches Summit in New York, FDA Center for Tobacco Products Director Bret Koplow said the PMTA pathway is “predicated on tobacco harm reduction.” He outlined four CTP priorities: youth prevention, helping adults quit or switch to lower-risk products, improving relative-risk communication, and reducing unauthorized products. Koplow also addressed flavored e-cigarettes, public risk perceptions, industry credibility and efforts to make PMTA reviews more efficient and predictable.
Sep.26
2Firsts Data|China’s Vape-Related Exports Rose 3.3% in August 2026 as UK Shipments Jumped 51.4% and U.S. Exports Fell 12.4%
2Firsts Data|China’s Vape-Related Exports Rose 3.3% in August 2026 as UK Shipments Jumped 51.4% and U.S. Exports Fell 12.4%
China exported $979 million of vape-related products in August 2026, up 3.3% from a year earlier but down 6.4% from July. The UK replaced the U.S. as the main source of growth: UK-bound shipments jumped 51.4% to a 2026 high of $177 million, while exports to the U.S. fell 12.4% to $339 million. Shipments to markets outside the U.S. increased 14.2%, broadening growth beyond the market that had driven July’s rebound.
News
Sep.23 by 2Firsts Perspectives